Germline mutations in BRCA1 and BRCA2, which account for roughly 15% of hereditary breast cancer cases, compromise DNA repair mechanisms, leading to genomic instability and increased tumorigenesis [9,10,11]. This evidence concerns the gene BRCA2 and breast carcinoma.